Addus HomeCare Corporation (NASDAQ:ADUS) Receives $130.88 Average Price Target from Analysts

Shares of Addus HomeCare Corporation (NASDAQ:ADUS) have received an average rating of “Moderate Buy” from the eleven brokerages that are currently covering the firm, Marketbeat reports. One research analyst has rated the stock with a sell recommendation, two have assigned a hold recommendation, seven have issued a buy recommendation and one has given a strong buy recommendation to the company. The average 1-year target price among brokers that have issued ratings on the stock in the last year is $130.8750.

ADUS has been the subject of a number of research reports. Barclays increased their target price on shares of Addus HomeCare from $92.00 to $96.00 and gave the stock an “underweight” rating in a report on Wednesday, July 8th. Citigroup reissued a “market outperform” rating on shares of Addus HomeCare in a research note on Friday, July 24th. Weiss Ratings upgraded shares of Addus HomeCare from a “hold (c-)” rating to a “hold (c)” rating in a research report on Thursday, July 9th. Citizens Jmp reaffirmed a “market outperform” rating and set a $142.00 target price on shares of Addus HomeCare in a research note on Monday, May 18th. Finally, Royal Bank Of Canada increased their price target on Addus HomeCare from $130.00 to $134.00 and gave the company an “outperform” rating in a research note on Wednesday, August 5th.

Addus HomeCare Stock Performance

Shares of ADUS opened at $115.55 on Monday. The company has a debt-to-equity ratio of 0.05, a quick ratio of 1.69 and a current ratio of 1.69. Addus HomeCare has a 52-week low of $87.95 and a 52-week high of $124.43. The firm has a market cap of $2.16 billion, a price-to-earnings ratio of 20.27, a PEG ratio of 1.55 and a beta of 0.87. The business’s fifty day moving average is $111.95 and its 200-day moving average is $102.96.

Addus HomeCare (NASDAQ:ADUS) last announced its quarterly earnings data on Monday, August 3rd. The company reported $1.73 earnings per share for the quarter, topping the consensus estimate of $1.70 by $0.03. Addus HomeCare had a return on equity of 9.96% and a net margin of 7.13%.The business had revenue of $377.41 million during the quarter, compared to the consensus estimate of $376.24 million. During the same period in the prior year, the company earned $1.49 EPS. Addus HomeCare’s revenue for the quarter was up 8.0% on a year-over-year basis. Equities analysts anticipate that Addus HomeCare will post 6.3 EPS for the current fiscal year.

Insiders Place Their Bets

In other Addus HomeCare news, insider Heather Brianne Dixon sold 288 shares of the company’s stock in a transaction dated Monday, June 22nd. The stock was sold at an average price of $93.77, for a total value of $27,005.76. Following the completion of the transaction, the insider owned 44,371 shares of the company’s stock, valued at $4,160,668.67. This represents a 0.64% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 4.10% of the stock is owned by corporate insiders.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently made changes to their positions in the company. Global Retirement Partners LLC boosted its position in Addus HomeCare by 395.7% during the 4th quarter. Global Retirement Partners LLC now owns 233 shares of the company’s stock worth $25,000 after buying an additional 186 shares during the period. Larson Financial Group LLC increased its position in Addus HomeCare by 133.3% in the 3rd quarter. Larson Financial Group LLC now owns 238 shares of the company’s stock valued at $28,000 after acquiring an additional 136 shares during the period. NFJ Investment Group LLC bought a new position in shares of Addus HomeCare during the second quarter valued at $29,000. Acumen Wealth Advisors LLC bought a new position in shares of Addus HomeCare during the fourth quarter valued at $29,000. Finally, Arax Advisory Partners grew its stake in shares of Addus HomeCare by 95.8% in the fourth quarter. Arax Advisory Partners now owns 280 shares of the company’s stock worth $30,000 after purchasing an additional 137 shares during the last quarter. Institutional investors and hedge funds own 95.35% of the company’s stock.

About Addus HomeCare

Addus HomeCare (NASDAQ: ADUS) is a leading provider of home and community-based care services for elderly, disabled, and medically complex individuals across the United States. Through a network of company-owned and franchise locations, the company delivers a broad spectrum of non-medical personal care and licensed home health services designed to support clients’ independence and quality of life.

The company’s core offerings include personal care assistance—covering daily living activities, medication reminders, and light housekeeping—and skilled home health services delivered under the supervision of registered nurses and licensed therapists.